Aster DM Healthcare moves up on completing acquisition of 5% stake in Quality Care India
Aster DM Healthcare is currently trading at Rs. 506.30, up by 1.30 points or 0.26% from its previous closing of Rs. 505.00 on the BSE.
The scrip opened at Rs. 503.55 and has touched a high and low of Rs. 509.70 and Rs. 497.15 respectively. So far 5617 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 534.00 on 07-Jan-2025 and a 52 week low of Rs. 312.25 on 04-Jun-2024.
Last one week high and low of the scrip stood at Rs. 519.55 and Rs. 492.70 respectively. The current market cap of the company is Rs. 24868.26 crore.
The promoters holding in the company stood at 41.89%, while Institutions and Non-Institutions held 46.24% and 11.86% respectively.
Aster DM Healthcare has completed the acquisition of a 5 per cent stake in Quality Care India (QCIL) in a deal worth Rs 849 crore. The company has acquired the stake in the firm from BCP Asia II TopCo IV (BCP) and Centella Mauritius Holdings (Centella) through a share swap ahead of Quality Care India.
QCIL's merger with Aster DM Healthcare was announced in November 2024. The acquisition of a 5 per cent stake in QCIL through a share swap is the first step toward the strategic merger between Aster DM Healthcare and QCIL. This move lays the foundation for a unified, future-ready healthcare network with a strengthened pan-India presence.
Aster DM Healthcare operates in multiple segments of the healthcare industry, including hospitals, clinics and retail pharmacies and provide healthcare services to patients across economic segments in several GCC states through its various brands ‘Aster’, ‘Medcare’ and ‘Access’.
